Latest Insider Transactions at Danaher Corp (DHR)
This section provides a real-time view of insider transactions for Danaher Corp (DHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DANAHER CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DANAHER CORP 's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 16
2024
|
Rainer Blair President & CEO |
SELL
Open market or private sale
|
Direct |
9,005
-7.76%
|
$2,386,325
$265.0 P/Share
|
May 15
2024
|
Alan G Spoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+0.33%
|
-
|
May 15
2024
|
Raymond C Stevens Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+3.36%
|
-
|
May 15
2024
|
William King SVP, Strategic Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,018
-12.71%
|
$1,845,734
$263.46 P/Share
|
May 15
2024
|
William King SVP, Strategic Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,623
+18.61%
|
$631,150
$50.37 P/Share
|
May 15
2024
|
Christopher Paul Riley Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-2.15%
|
$84,160
$263.46 P/Share
|
May 15
2024
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+12.52%
|
-
|
May 15
2024
|
John T Schwieters Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+2.31%
|
-
|
May 15
2024
|
Feroz Dewan Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+14.93%
|
-
|
May 15
2024
|
A Shane Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+10.66%
|
-
|
May 15
2024
|
Georgeann Couchara SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-5.16%
|
$73,903
$263.46 P/Share
|
May 15
2024
|
Teri List Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+1.9%
|
-
|
May 15
2024
|
Joakim Weidemanis Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,079
-3.41%
|
$809,777
$263.46 P/Share
|
May 15
2024
|
Linda Filler Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+0.94%
|
-
|
May 15
2024
|
Elias A. Zerhouni Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+1.13%
|
-
|
May 15
2024
|
Pardis C Sabeti Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+6.88%
|
-
|
May 14
2024
|
Rainer Blair President & CEO |
SELL
Open market or private sale
|
Direct |
19,085
-14.13%
|
$4,866,675
$255.0 P/Share
|
May 14
2024
|
Rainer Blair President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,085
+6.76%
|
$1,145,100
$60.72 P/Share
|
May 10
2024
|
Matthew Mc Grew EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,377
-33.65%
|
$11,733,381
$253.07 P/Share
|
May 10
2024
|
Matthew Mc Grew EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,174
+22.65%
|
$1,510,440
$60.66 P/Share
|
May 02
2024
|
Alan G Spoon Director |
SELL
Open market or private sale
|
Direct |
708
-0.61%
|
$172,044
$243.58 P/Share
|
May 02
2024
|
Alan G Spoon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,289
+2.74%
|
$171,028
$52.56 P/Share
|
Apr 25
2024
|
Joakim Weidemanis Executive Vice President |
SELL
Open market or private sale
|
Direct |
22,433
-19.88%
|
$5,608,250
$250.46 P/Share
|
Apr 25
2024
|
Joakim Weidemanis Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,433
+16.58%
|
$1,301,114
$58.48 P/Share
|
Apr 24
2024
|
Rainer Blair President & CEO |
SELL
Open market or private sale
|
Direct |
47,175
-15.98%
|
$11,746,575
$249.51 P/Share
|
Apr 24
2024
|
Rainer Blair President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
38,170
+11.53%
|
$2,290,200
$60.72 P/Share
|
Apr 24
2024
|
Brian W Ellis Senior Vice President - GC |
SELL
Open market or private sale
|
Direct |
4,000
-11.82%
|
$1,000,000
$250.01 P/Share
|
Mar 01
2024
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,932
+18.45%
|
-
|
Mar 01
2024
|
Georgeann Couchara SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,466
+21.21%
|
-
|
Mar 01
2024
|
Joakim Weidemanis Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
978
+1.07%
|
-
|
Mar 01
2024
|
Christopher Bouda VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
978
+11.48%
|
-
|
Feb 26
2024
|
Christopher Bouda VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-4.84%
|
$84,502
$253.84 P/Share
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
SELL
Open market or private sale
|
Direct |
23,757
-38.41%
|
$5,986,764
$252.0 P/Share
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
23,757
+27.75%
|
$1,377,906
$58.48 P/Share
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
SELL
Bona fide gift
|
Direct |
591
-1.53%
|
-
|
Feb 26
2024
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
866
-7.95%
|
$219,098
$253.84 P/Share
|
Feb 26
2024
|
Christopher Paul Riley Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-3.49%
|
$136,367
$253.84 P/Share
|
Feb 26
2024
|
Georgeann Couchara SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-6.24%
|
$67,045
$253.84 P/Share
|
Feb 21
2024
|
Joakim Weidemanis Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
7,880
+8.1%
|
-
|
Feb 21
2024
|
Christopher Paul Riley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
2,367
+13.29%
|
-
|
Feb 21
2024
|
Matthew Mc Grew EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,911
+10.46%
|
-
|
Feb 21
2024
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,155
+22.46%
|
-
|
Feb 21
2024
|
Daniel Raskas SVP - Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+8.23%
|
-
|
Feb 21
2024
|
Brian W Ellis Senior Vice President - GC |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+10.44%
|
-
|
Feb 21
2024
|
William King SVP, Strategic Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+7.54%
|
-
|
Feb 21
2024
|
Rainer Blair President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,698
+13.61%
|
-
|
Feb 15
2024
|
Walter G Lohr Director |
SELL
Open market or private sale
|
Direct |
3,289
-18.88%
|
$825,539
$251.15 P/Share
|
Feb 15
2024
|
Walter G Lohr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,289
+15.88%
|
$171,028
$52.56 P/Share
|
Feb 13
2024
|
Georgeann Couchara SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
2,622
-23.06%
|
$634,524
$242.67 P/Share
|
Feb 13
2024
|
Georgeann Couchara SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,622
+18.51%
|
$175,674
$67.53 P/Share
|